Retatrutide (LY3437943) is an investigational medicinal product (IMP) a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors currently under clinical evaluation for obesity and metabolic disease
Accessed on December 14, 2023 at HIVinfo
Its truly an amazing medication that has helped me achieve my weight loss goals with remarkable ease. -Jessica L
Eat a light breakfast, hydrate well, and proceed with your day
Options may include switching to a different medication such as retatrutide or semaglutide, adding a complementary medication, investigating underlying conditions more thoroughly, or considering whether the non-response is actually a medication quality issue
While Spirulina cultivation can be resource-efficient, energy consumption remains a critical factor